¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"cell labelling technique"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
cell labeling technique
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
basosquamous cell acanthoma
¹Ù´ÚÆíÆò¼¼Æ÷°¡½Ã¼¼Æ÷Á¾, ±âÀúÆíÆò±Ø¼¼Æ÷Á¾
basosquamous cell carcinoma
¹Ù´ÚÆíÆò¼¼Æ÷¾ÏÁ¾, ±âÀúÆíÆò¼¼Æ÷¾ÏÁ¾
beta cell
º£Å¸¼¼Æ÷
bipolar cell
µÎ±Ø¼¼Æ÷
blast cell
¸ð¼¼Æ÷
blood cell
Ç÷¾×¼¼Æ÷, Ç÷±¸
blood cell separator
Ç÷±¸ºÐ¸®±â
bone marrow-derived cell
°ñ¼öÀ¯·¡¼¼Æ÷
border cell
°æ°è¼¼Æ÷, ¼Ó°æ°è¼¼Æ÷
balloon cell
dz¼±¼¼Æ÷
balloon cell nevus
dz¼±¼¼Æ÷¸ð¹Ý
bristle cell
¾ï¼¾Åм¼Æ÷, °¸ð¼¼Æ÷
burr cell
¹«µòÅ鳯ÀûÇ÷±¸
ciliated cell
¼¶¸ð¼¼Æ÷
clear cell
Åõ¸í¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
red cell aplasia
ÀûÇ÷±¸¹«Çü¼º
sickle cell anemia
³´ÀûÇ÷±¸ºóÇ÷
subependymal giant cell astrocytoma
³ú½Ç¸·¹Ø°Å´ë¼¼Æ÷º°¼¼Æ÷Á¾, »óÀÇÇϰŴ뼼Æ÷º°¼¼Æ÷Á¾
target cell anemia
Ç¥ÀûÀûÇ÷±¸ºóÇ÷
balloon cell
dz¼±¼¼Æ÷
balloon cell melanoma
dz¼±¼¼Æ÷Èæ»öÁ¾
balloon cell nevus
dz¼±¼¼Æ÷¸ð¹Ý
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
basal cell epithelioma
¹Ù´Ú¼¼Æ÷»óÇÇÁ¾, ±âÀú¼¼Æ÷»óÇÇÁ¾
basal cell nevus
¹Ù´Ú¼¼Æ÷¸ð¹Ý, ±âÀú¼¼Æ÷¸ð¹Ý
basal cell nevus syndrome
¹Ù´Ú¼¼Æ÷¸ð¹ÝÁõÈıº, ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº
basket cell
¹Ù±¸´Ï¼¼Æ÷
basophilic cell
È£¿°±â¼¼Æ÷
basosquamous cell carcinoma
¹Ù´ÚÆíÆò¼¼Æ÷¾ÏÁ¾, ±âÀúÆíÆò¼¼Æ÷¾ÏÁ¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
T cell growth factor (TCGF, IL-2)
T¼¼Æ÷ Áõ½ÄÀÎÀÚ
T cell hybridoma
T¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
T cell immunity
T¼¼Æ÷¸é¿ª
T cell leukemia
T¼¼Æ÷(¹éÇ÷º´
T cell lymphoma
T¼¼Æ÷¸²ÇÁÁ¾
T cell receptor
T¼¼Æ÷[Ç׿ø]¼ö¿ëü
T cell receptor gene
T¼¼Æ÷[Ç׿ø]¼ö¿ëü À¯ÀüÀÚ
T cell replacing factor
T¼¼Æ÷ ´ëüÀÎÀÚ
T cell/lymphocyte
T ¼¼Æ÷/¸²ÇÁ±¸
T-cell
T-¼¼Æ÷
T-cell differentiation
T-¼¼Æ÷ºÐÈ
T-cell growth factor
T-¼¼Æ÷¼ºÀåÀÎÀÚ
Th cell
Th¼¼Æ÷, Á¶·ÂT¼¼Æ÷, º¸Á¶T¼¼Æ÷
Ts cell
¾ïÁ¦T¼¼Æ÷
Tzanck cell
Á¤Å© ¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
statistical control technique
Åë°èÀû Á¶Á¤¹ý
sterile technique
¹«±Õ¼ú(Ùíжâú), ¹«±Õ¹ý(ÙíжÛö).
stop flow technique
À¯ÅëÁ¤Áö¹ý(¡ïÎòÛö).
stop-start technique
Á¤Áö-½ÃÀÛ ±â¹ý(ÐüÛö).
technique, play
³îÀ̱â¹ý.
three field isocentric technique
»ï¿µ¿ªµîÁß½ÉÁ¶»ç¹ý
transfontanelle technique
°æÃµ¹® ±â¹ý
transmastoid translabyrinthine technique
°æÀ¯µ¹¹Ì·ÎÁ¢±Ù(¹ý)
turbidometric technique
ȥʵµÃøÁ¤±â¹ý
two field technique
ÀÌ¿ªÁ¶»ç¹ý
two voltage testing technique
ÀÌÀü¾Ð½ÃÇè¹ý
ultrasonic technique
ÃÊÀ½ÆÄ ±â¹ý
utilization technique
ÀÌ¿ë±â¼ú.
van Lint technique
¹Ý¸°Æ®¹ý
variable bandwidth technique
´Ùº¯ Á֯ļöÆø ±â¹ý
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½